News | April 25, 2022
Global AYUSH meet ends with promise of Rs 9000 cr. in investment
Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal
Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal
If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Fujifilm’s NEVER STOP philosophy to enhance the access to healthcare for all Indians
The peptide-based vaccine induces a t cell-dependent response
Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting
If authorized by the USFDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for Covid-19 in as little as 18 minutes
Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"
Under this initiative, 700 meals will be provided every day to four hospitals in Mumbai
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
